This is so contrary to the most studies’ findings which report the significantly higher amount of sHLA-G in breast cancer and other cancer patients than in normal controls (Ugurel et al., 2001; Jeong et al., 2014; Pan et al., 2016; He et al., 2010). This evidence concerns the gene HLA-G and breast carcinoma.